← SynDRA
BALAGLITAZONE
SynDRA canonical compound SYN0030137 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PPARG |
|---|
| Mechanism of action | PPAR receptor partial agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Insulin sensitizer
- PPAR receptor partial agonist
- PPARG PARTIAL AGONIST
- Peroxisome proliferator-activated receptor gamma partial agonist
- PPARG MODULATOR
Cross-references
Synonyms
- Balaglitazona
- DRF-2593
- NN-2344
- DRF-2593-307
- NNC-61-0645
- DRF 2593
- NN 2344
- balaglitazona
- 4M1609828O
- balaglitazonum
- RefChem:116359
- DTXCID80817996
- Balaglitazone [INN]
- DRF 2593;NN 2344
- Balaglitazone?
- UNII-4M1609828O
- MFCD09837808
- NN2344
- SCHEMBL242011
- BALAGLITAZONE [WHO-DD]
- orb1679005
- SCHEMBL29362039
- IETKPTYAGKZLKY-UHFFFAOYSA-N
- GLXC-10736
- EX-A3756
- ZHA11398
- TQ0272
- AKOS030526698
- CS-1441
- SB16864
- NNC-61-2344
- AS-74629
- HY-16086
- DB-065992
- F84947
- DRF-2593;NN-2344;NNC-610645
- F862135
- BRD-A00147595-001-01-5
Look up BALAGLITAZONE in the interactive SynDRA portal →